Alan F. Denenberg
Lawyers
Filters
Marvell Technology private exchange offers
We advised the dealer manager in connection with the private exchange offers
EDAP TMS $28 million follow-on offering
We advised the underwriters on the equity offering
NeuroPace $102 million IPO
We advised the underwriters in connection with the IPO and Nasdaq listing
UiPath $1.54 billion IPO
The shares are listed on the New York Stock Exchange
Recursion Pharmaceuticals $500 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Alkami Technology $207 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Ultra Clean $175 million follow-on offering
We advised Ultra Clean on its SEC-registered equity offering
Ionis Pharmaceuticals $632.5 million convertible senior notes offering
We advised the purchasers on the Rule 144A convertible notes offering
Maravai LifeSciences $646.9 million secondary offering
We advised the joint book-running managers on the equity offering
Marvell Technology $2 billion senior notes offering
We advised the initial purchasers on the unregistered debt offering